2012Yiyao daobaoRequires access

Relative Bioavailability and Bioequivalence of Zopiclone Tablets in Healthy Volunteers

Dong Liu

Open publisher page 0 citations

Abstract

Objective To investigate the pharmacokinetics and bioequivalence of zopiclone test and control tablets in health volunteers.Methods A single oral dose of 15 mg zopiclone test or control tablets were given to 20 healthy male volunteers in a randomized,two-way crossway study.HPLC-fluorescence detector was used to determine the concentration of zopiclone in plasma.By the DAS 2.1 pharmacokinetic software,the pharmacokinetic parameters of the two preparations were calculated and the bioequivalence of two tablets was evaluated.Results The main pharmacokinetic parameters of test and control preparations were as follows: t1/2 were(4.93±2.45) and(5.46±2.51) h;Cmax were(101.18±23.47) and(105.39±35.21) ng·mL-1;tmax were(1.60±1.16) and(1.64±1.35) h;AUC0-24 were(612.66±157.35) and(617.27±207.11) ng·h·mL-1;AUC0-∞ was(664.88±160.27) and(679.12±223.75) ng·h·mL-1;The relative bioavailability of test preparations(F0-t) was calculated to be(105.1±28.9)% according to AUC0-t.Conclusion The two kinds of domestic preparations are bioequivalent.

About this research paper

What this paper is about

Objective To investigate the pharmacokinetics and bioequivalence of zopiclone test and control tablets in health volunteers.Methods A single oral dose of 15 mg zopiclone test or control tablets were given to 20 healthy male volunteers in a randomized,two-way crossway study.HPLC-fluorescence detector was used to determine the concentration of zopiclone in plasma.By the DAS 2.1 pharmacokinetic software,the pharmacokinetic parameters of the two preparations were calculated and the bioequivalence of two tablets was evaluated.Results The main pharmacokinetic parameters of test and control preparations were as follows: t1/2 were(4.93±2.45) and(5.46±2.51) h;Cmax were(101.18±23.47) and(105.39±35.21) ng·mL-1;tmax were(1.60±1.16) and(1.64±1.35) h;AUC0-24 were(612.66±157.35) and(617.27±207.11) ng·h·mL-1;AUC0-∞ was(664.88±160.27) and(679.12±223.75) ng·h·mL-1;The relative bioavailability of test preparations(F0-t) was calculated to be(105.1±28.9)% according to AUC0-t.Conclusion The two kinds of domestic preparations are bioequivalent.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the pharmacokinetics and bioequivalence of zopiclone test and control tablets in health volunteers.Methods A single oral dose of 15 mg zopiclone test or control tablets were given to 20 healthy male volunteers in a randomized,two-way crossway study.HPLC-fluorescence detector was used to determine the concentration of zopiclone in plasma.By the DAS 2.1 pharmacokinetic software,the pharmacokinetic parameters of the two preparations were calculated and the bioequivalence of two tablets was evaluated.Results The main pharmacokinetic parameters of test and control preparations were as follows: t1/2 were(4.93±2.45) and(5.46±2.51) h;Cmax were(101.18±23.47) and(105.39±35.21) ng·mL-1;tmax were(1.60±1.16) and(1.64±1.35) h;AUC0-24 were(612.66±157.35) and(617.27±207.11) ng·h·mL-1;AUC0-∞ was(664.88±160.27) and(679.12±223.75) ng·h·mL-1;The relative bioavailability of test preparations(F0-t) was calculated to be(105.1±28.9)% according to AUC0-t.Conclusion The two kinds of domestic preparations are bioequivalent.

Key concepts: Bioequivalence, Bioavailability, Pharmacokinetics, Cmax, Zopiclone, Pharmacology, Medicine, Plasma concentration

Related papers

Back to paper searchBrowse research topicsOriginal source
Relative Bioavailability and Bioequivalence of Zopiclone Tablets in Healthy Volunteers — Research Paper | ScholarLens